These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19166935)

  • 1. Analysis of indirect pathway CD4+ T cells in a patient with metastable tolerance to a kidney allograft: possible relevance to superior graft survival of HLA class II closely matched renal allografts.
    Xu Q; Lee J; Keller M; Burlingham WJ
    Transpl Immunol; 2009 Mar; 20(4):203-8. PubMed ID: 19166935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
    Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
    Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide analogues as a strategy to induce tolerance in T cells with indirect allospecificity.
    Frasca L; Tamir A; Jurcevic S; Marinari B; Monizio A; Sorrentino R; Carbonari M; Piccolella E; Lechler RI; Lombardi G
    Transplantation; 2000 Aug; 70(4):631-40. PubMed ID: 10972222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An HLA-DRB1-derived peptide associated with protection against rheumatoid arthritis is naturally processed by human APCs.
    Snijders A; Elferink DG; Geluk A; van Der Zanden AL; Vos K; Schreuder GM; Breedveld FC; de Vries RR; Zanelli EH
    J Immunol; 2001 Apr; 166(8):4987-93. PubMed ID: 11290778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory function of human CD4+ cytolytic T lymphocytes.
    Poindexter NJ; Smith MA; Haynes AE; Mohanakumar T
    Transpl Immunol; 1999 Mar; 7(1):45-9. PubMed ID: 10375077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory functions of self-restricted MHC class II allopeptide-specific Th2 clones in vivo.
    Waaga AM; Gasser M; Kist-van Holthe JE; Najafian N; Müller A; Vella JP; Womer KL; Chandraker A; Khoury SJ; Sayegh MH
    J Clin Invest; 2001 Apr; 107(7):909-16. PubMed ID: 11285310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indirect allorecognition of HLA class I peptides by CD4+ cytolytic T lymphocytes.
    Susskind B; Iannotti MR; Shornick MD; Steward NS; Gorka J; Mohanakumar T
    Hum Immunol; 1996 Mar; 46(1):1-9. PubMed ID: 9157083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indirect allorecognition in acquired thymic tolerance: induction of donor-specific tolerance to rat cardiac allografts by allopeptide-pulsed host dendritic cells.
    Garrovillo M; Ali A; Oluwole SF
    Transplantation; 1999 Dec; 68(12):1827-34. PubMed ID: 10628758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and function of transgenic HLA-DQ molecules and lymphocyte development in mice lacking invariant chain.
    Rajagopalan G; Smart MK; Krco CJ; David CS
    J Immunol; 2002 Aug; 169(4):1774-83. PubMed ID: 12165499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction.
    Vella JP; Spadafora-Ferreira M; Murphy B; Alexander SI; Harmon W; Carpenter CB; Sayegh MH
    Transplantation; 1997 Sep; 64(6):795-800. PubMed ID: 9326400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/ regulatory T cells.
    Le Rond S; Azéma C; Krawice-Radanne I; Durrbach A; Guettier C; Carosella ED; Rouas-Freiss N
    J Immunol; 2006 Mar; 176(5):3266-76. PubMed ID: 16493088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delineating the role of the HLA-DR4 "shared epitope" in susceptibility versus resistance to develop arthritis.
    Taneja V; Behrens M; Basal E; Sparks J; Griffiths MM; Luthra H; David CS
    J Immunol; 2008 Aug; 181(4):2869-77. PubMed ID: 18684978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid deletional peripheral CD8 T cell tolerance induced by allogeneic bone marrow: role of donor class II MHC and B cells.
    Fehr T; Wang S; Haspot F; Kurtz J; Blaha P; Hogan T; Chittenden M; Wekerle T; Sykes M
    J Immunol; 2008 Sep; 181(6):4371-80. PubMed ID: 18768896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The humoral immune response against an HLA class I allodeterminant correlates with the HLA-DR phenotype of the responder.
    Fuller TC; Fuller A
    Transplantation; 1999 Jul; 68(2):173-82. PubMed ID: 10440383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of tolerance to a maternal kidney transplant is selective for HLA class II: evidence from trans-vivo DTH and alloantibody analysis.
    Burlingham WJ; Jankowska-Gan E; VanBuskirk A; Orosz CG; Lee JH; Kusaka S
    Hum Immunol; 2000 Dec; 61(12):1395-402. PubMed ID: 11163098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of donor and recipient antigen-presenting cells in priming and maintaining T cells with indirect allospecificity.
    Frasca L; Amendola A; Hornick P; Brookes P; Aichinger G; Marelli-Berg F; Lechler RI; Lombardi G
    Transplantation; 1998 Nov; 66(9):1238-43. PubMed ID: 9825823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DR4 (DRB1*0401) transgenic mice expressing an altered CD4-binding site: specificity and magnitude of DR4-restricted T cell response.
    Pan S; Trejo T; Hansen J; Smart M; David CS
    J Immunol; 1998 Sep; 161(6):2925-9. PubMed ID: 9743354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA class II-restricted antigen presentation of endogenous bcr-abl fusion protein by chronic myelogenous leukemia-derived dendritic cells to CD4(+) T lymphocytes.
    Yasukawa M; Ohminami H; Kojima K; Hato T; Hasegawa A; Takahashi T; Hirai H; Fujita S
    Blood; 2001 Sep; 98(5):1498-505. PubMed ID: 11520800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+CD25+Foxp3+ indirect alloreactive T cells from renal transplant patients suppress both the direct and indirect pathways of allorecognition.
    Spadafora-Ferreira M; Caldas C; Faé KC; Marrero I; Monteiro SM; Lin-Wang HT; Socorro-Silva A; Fonseca SG; Fonseca JA; Kalil J; Coelho V
    Scand J Immunol; 2007; 66(2-3):352-61. PubMed ID: 17635813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical transplantation tolerance twelve years after prospective withdrawal of immunosuppressive drugs: studies of chimerism and anti-donor reactivity.
    Strober S; Benike C; Krishnaswamy S; Engleman EG; Grumet FC
    Transplantation; 2000 Apr; 69(8):1549-54. PubMed ID: 10836360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.